MONTE ROSA THERAPEUTICS INC Share Price Today: Live Updates & Key Insights

MONTE ROSA THERAPEUTICS INC share price today is $15.95, up -2.68%. The stock opened at $15.96 against the previous close of $16.06, with an intraday high of $16.23 and low of $15.65.

MONTE ROSA THERAPEUTICS INC Share Price Chart

MONTE ROSA THERAPEUTICS INC

us-stock
To Invest in {{usstockname}}
us-stock

MONTE ROSA THERAPEUTICS INC Share Price Performance

$15.95 -0.0268(-2.68%) GLUE at 23 Mar 2026 01:20 PM Biotechnology
Lowest Today 15.65
Highest Today 16.23
Today’s Open 15.96
Prev. Close 16.06
52 Week High 25.77
52 Week Low 3.50
Day’s Range: Low 15.65 High 16.23
52-Week Range: Low 3.50 High 25.77
1 day return -
1 Week return -4.15
1 month return -19.68
3 month return -3.15
6 month return +140.15
1 year return +169.7
3 year return +123.85
5 year return -28.11
10 year return -

MONTE ROSA THERAPEUTICS INC Institutional Holdings

NEA Management Company, LLC 10.09

Versant Venture Management LLC 7.41

T. Rowe Price Associates, Inc. 6.08

Baker Bros Advisors LP 5.70

Bvf Inc 5.03

BlackRock Inc 5.00

Suvretta Capital Management, LLC 4.41

Vanguard Group Inc 4.26

Vanguard Total Stock Mkt Idx Inv 2.83

Avantis US Small Cap Value ETF 2.76

T. Rowe Price New Horizons 2.63

T. Rowe Price Health Sciences 2.61

US Small-Cap Growth II Equity Comp 2.24

FIAM Small Cap Core Composite 2.08

Aisling Capital Management LP 1.93

Alphabet Inc 1.92

HBM Healthcare Investments AG Ord 1.85

American Century Companies Inc 1.74

FMR Inc 1.71

Geode Capital Management, LLC 1.58

iShares Russell 2000 ETF 1.49

State Street® SPDR® S&P® Biotech ETF 1.47

SILVERARC CAPITAL MANAGEMENT, LLC 1.35

BRAIDWELL LP 1.24

State Street Corp 1.11

AQR Capital Management LLC 1.03

Vestal Point Capital LP 1.02

FIAM Small Cap Core CIT Cl B 0.98

Northern Trust Corp 0.97

T. Rowe Price New Horizons Tr-A 0.96

Parkwood LLC 0.93

Vanguard Institutional Extnd Mkt Idx Tr 0.87

T. Rowe Price Integrated US Sm Gr Eq 0.74

T. Rowe Price Integrated US SmCapGrEq 0.70

Fidelity Small Cap Index 0.60

iShares Russell 2000 Value ETF 0.53

iShares Biotechnology ETF 0.47

Fidelity Extended Market Index 0.42

BlackRock Health Sciences Opps Inv A 0.42

MEDICAL BioHealth EUR Acc 0.40

MONTE ROSA THERAPEUTICS INC Market Status

Strong Buy: 6

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

MONTE ROSA THERAPEUTICS INC Fundamentals

Market Cap 1250.64 M

PB Ratio 4.9808

PE Ratio 0.0

Enterprise Value 912.73 M

Total Assets 448.66 M

Volume 5472710

MONTE ROSA THERAPEUTICS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-132882000 -132.9M, FY22:-104618000 -104.6M, FY21:-71942000 -71.9M, FY20:-36068000 -36.1M, FY19:-8017000 -8.0M

Quarterly Revenue Q3/2025:12768000 12.8M, Q2/2025:23194000 23.2M, Q1/2025:84929000 84.9M, Q3/2024:9216000 9.2M, Q2/2024:4695000 4.7M

Quarterly Profit Q3/2025:10673000 10.7M, Q2/2025:23194000 23.2M, Q1/2025:84929000 84.9M, Q3/2024:9216000 9.2M, Q2/2024:2635000 2.6M

Quarterly Net worth Q3/2025:-27081000 -27.1M, Q2/2025:-12295000 -12.3M, Q1/2025:46885000 46.9M, Q3/2024:-23859000 -23.9M, Q2/2024:-30310000 -30.3M

About MONTE ROSA THERAPEUTICS INC & investment objective

Company Information Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of inflammatory diseases driven by IL-1a, IL-1ß and IL-18, as well as damage-associated molecular patterns. In addition, it develops CDK2 to treat multiple cancers, including ovarian, endometrial, gastric and breast. Further, its pipeline includes programs in immunology and inflammation indications, oncology, cardiovascular, metabolic, and genetic diseases. The company also develops QuEEN, a discovery engine, to enable its target-centric MGD discovery and development approach and its rational design of MGD product candidates. It has a strategic collaboration and licensing agreement with F. Hoffmann-La Roche Ltd.; and Novartis. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.

Organisation Biotechnology

Employees 150

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

MONTE ROSA THERAPEUTICS INC FAQs

What is the share price of MONTE ROSA THERAPEUTICS INC today?

The current share price of MONTE ROSA THERAPEUTICS INC is $15.95.

Can I buy MONTE ROSA THERAPEUTICS INC shares in India?

Yes, Indian investors can buy MONTE ROSA THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy MONTE ROSA THERAPEUTICS INC shares in India?

You can easily invest in MONTE ROSA THERAPEUTICS INC shares from India by:

Can I buy fractional shares of MONTE ROSA THERAPEUTICS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of MONTE ROSA THERAPEUTICS INC?

MONTE ROSA THERAPEUTICS INC has a market cap of $1250.64 M.

In which sector does MONTE ROSA THERAPEUTICS INC belong?

MONTE ROSA THERAPEUTICS INC operates in the Biotechnology sector.

What documents are required to invest in MONTE ROSA THERAPEUTICS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of MONTE ROSA THERAPEUTICS INC?

The PE ratio of MONTE ROSA THERAPEUTICS INC is N/A and the PB ratio is 4.98.